Advance on clinical and fundamental research of classic prescription Yiguanjian Decoction in treating chronic liver diseases

Jiaqi ZHENG; Dingqi ZHANG; Xun JIAN; Wei LIU; Jiamei CHEN; Yongping MU; Ying XU

doi:10.16305/j.1007-1334.2021.2003280

您当前的位置：

首页 >

文章列表页 >

Advance on clinical and fundamental research of classic prescription Yiguanjian Decoction in treating chronic liver diseases

更新时间：2022-08-03

- Advance on clinical and fundamental research of classic prescription Yiguanjian Decoction in treating chronic liver diseases
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 6, Pages: 96-100(2021)
- 作者机构：
  
  1.上海中医药大学（上海　201203）
  2.上海中医药大学附属曙光医院（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2003280
  CLC：
扫描看全文
Jiaqi ZHENG, Dingqi ZHANG, Xun JIAN, et al. Advance on clinical and fundamental research of classic prescription Yiguanjian Decoction in treating chronic liver diseases. [J]. Shanghai Journal of Traditional Chinese Medicine 55(6):96-100(2021)
DOI：

Jiaqi ZHENG, Dingqi ZHANG, Xun JIAN, et al. Advance on clinical and fundamental research of classic prescription Yiguanjian Decoction in treating chronic liver diseases. [J]. Shanghai Journal of Traditional Chinese Medicine 55(6):96-100(2021) DOI： 10.16305/j.1007-1334.2021.2003280.

摘要

从临床研究、基础研究两个方面综述一贯煎治疗慢性肝病的研究进展。一贯煎对肝纤维化及肝硬化、原发性肝癌、病毒性肝炎、非酒精性脂肪性肝病等慢性肝病均有疗效，能有效缓解患者的临床症状、改善肝脏相关指标及并发症。在作用机制方面，一贯煎可以调控机体多种信号通路，如核因子活化B细胞κ轻链增强子（NF-κB）信号通路、Notch信号通路、Wnt信号通路、酪氨酸激酶1/信号转导和转录活化因子1（JAK1/STAT1）信号通路、胞外信号调控激酶（ERK）信号通路、磷脂酰肌醇三激酶-丝氨酸/苏氨酸激酶（PI3K-Akt）信号通路，以及肿瘤坏死因子-α（TNF-α）相关蛋白表达，进而多环节、多靶点地发挥作用。

Abstract

This paper reviewed the clinical and fundamental research progress of Yiguanjian Decoction in treating chronic liver diseases. Yiguanjian Decoction shows curative effects on chronic liver diseases such as liver fibrosis, liver cirrhosis, primary liver cancer, viral hepatitis, and nonalcoholic fatty liver disease, etc. as it can effectively relieve the clinical symptoms of patients and improve liver-related biomedical indexes and complications. In terms of mechanism of action, Yiguanjian Decoction can have multi-link and multi-target effects by regulating and controlling various signaling pathways inside the body, such as NF-kappa B (NF-κB) signaling pathway, Notch signaling pathway, Wnt signaling pathway, tyrosine kinase 1/signal transducer and activator of transcription 1 (JAK1/STAT1) signaling pathway, extracellular signal regulated kinase (ERK) signaling pathway, phosphatidylinositol 3 kinase/protein kinase B (PI3K-Akt)signaling pathway, and the expression of tumor necrosis factor (TNF-α) related proteins.

关键词

慢性肝病经典名方一贯煎综述

Keywords

chronic liver diseaseclassic prescriptionYiguanjian Decoctionreview

references

徐列明. 《肝纤维化中西医结合诊疗指南（2019年版）》解读[J]. 上海中医药杂志，2020, 54(3): 29-352.

慕永平，刘平. 中西医结合抗肝纤维化的研究思路与方法[J]. 上海医药，2016, 37(13): 8-12.

徐韶敏. 四君子汤合一贯煎加味对慢性乙型肝炎患者肝纤维化指标的影响[J]. 辽宁中医药大学学报，2009, 11(3): 89-90.

段淑红，鲍中英，苑晓冬，等. 一贯煎加味联合阿德福韦酯片治疗HBeAg阴性慢性乙型肝炎活动性代偿期肝硬化患者的疗效观察[J]. 中国中西医结合杂志，2016, 36(5): 535-538.

张爽. 加减一贯煎联合恩替卡韦治疗代偿期乙肝肝硬化的临床观察[D]. 济南：山东中医药大学，2018.

袁志军，刘乡，朱海容，等. 一贯煎加味联合恩替卡韦胶囊治疗慢性乙型肝炎后肝硬化的临床疗效及对肝功能及肝纤维化的影响[J]. 四川中医，2020, 38(5): 124-127.

张锡兰. 中药复方联合恩替卡韦治疗HBeAg阳性慢性乙型肝炎患者疗效观察[J]. 世界中西医结合杂志，2016, 11(12): 1728-1730.

倪灵灵，陈维娇. 一贯煎加味联合奥曲肽治疗乙肝肝硬化腹水临床研究[J]. 亚太传统医药，2019, 15(4): 144-146.

崔璀，张志勇，薛敬东. 一贯煎合猪苓汤联合西药治疗肝肾阴虚型肝硬化腹水临床观察[J]. 新中医，2017, 49(2): 51-54.

夏婷，尹剑雄. 一贯煎加减治疗肝硬化腹水的疗效观察[J]. 医学信息，2019, 32(6): 166-168.

常征斌. 一贯煎加味联合西药治疗乙型病毒性肝炎肝硬化腹水的临床观察[J]. 中国民间疗法，2020, 28(1): 58-59.

ALLAIRE M, NAULT J C. Advances in management of hepatocellular carcinoma[J]. Curr Opin Oncol, 2017, 29(4): 288-295.

刘平. 加强中西医结合防治肝癌的临床研究[J]. 临床肝胆病杂志，2016, 32(4): 615-618.

张丽红，庄志江，王继成，等. 加味一贯煎联合氩氦刀冷冻消融术治疗中晚期肝癌临床研究[J]. 中医学报，2015, 30(8): 1092-1094.

孙艳. 加味一贯煎联合甲磺酸阿帕替尼对晚期原发性肝癌患者疗效及生存质量的影响[J]. 云南中医中药杂志，2019, 40(4): 56-57.

雷震霄. 一贯煎合膈下逐瘀汤治疗中晚期原发性肝癌临床研究[J]. 河南中医，2016, 36(3): 471-472.

黄紫红，蒲柯，解新科，等. 一贯煎加减治疗气阴不足型慢性乙型肝炎81例[J]. 实用中西医结合临床，2015, 15(5): 64-65.

黄覃凤，韦艾凌，张永琴. 慢性丙型肝炎中医治疗进展[J]. 河北中医，2015, 37(11): 1746-1748.

RHEE E J. Nonalcoholic fatty liver disease and diabetes：An epidemiological perspective[J]. Endocrinol Metab (Seoul), 2019, 34(3): 226-233.

STREY C B M, DE CARLI L A, FANTINELLI M, et al. Impact of diabetes mellitus and insulin on nonalcoholic fatty liver disease in the morbidly obese[J]. Ann Hepatol, 2018, 17(4): 585-591.

杨斯皓，马方霞，詹云. 一贯煎合六味地黄汤配合西药治疗2型糖尿病合并非酒精性脂肪肝临床疗效及对患者生活质量的评价[J]. 陕西中医，2019, 40(8): 1006-1009.

何福强，陈天然. 一贯煎加减治疗2型糖尿病合并脂肪肝临床研究[J]. 亚太传统医药，2017, 13(22): 128-129.

单思，谢斌，严小军，等. 一贯煎治疗肝癌的分子机制生物信息学分析[J]. 中华中医药杂志，2018, 33(5): 1804-1807.

谢斌，饶斌，余功，等. 一贯煎单用及与化疗联用对荷H22肝癌小鼠MMP9和NF-κB蛋白表达的影响[J]. 江西中医药大学学报，2015, 27(6): 60-62.

谢斌，饶斌，谢雄，等. 一贯煎对荷H22肝癌小鼠AQP9及GK蛋白表达的影响[J]. 江西中医药大学学报，2016, 28(1): 71-74.

刘婷，丁艳，杨婷婷，等. 鲜枸杞子提取物通过p38 MAPK信号通路抑制人肝癌细胞HepG2诱导小鼠恶病质的作用及机制[J]. 中国实验方剂学杂志，2019, 25(9): 89-94.

刘建中，胡广军，时玲玲，等. Notch信号通路对肝癌细胞迁移的调控机制研究[J]. 癌症进展，2016, 14(10): 977-981.

孙福慧，车念聪，唐佐青，等. 基于Notch通路研究一贯煎逆转肝纤维化的作用机制[J]. 环球中医药，2019, 12(9): 1308-1312.

杨慧玲，刘小静，秦丽君，等. 乙型肝炎病毒感染对Wnt/β-catenin信号通路的影响机制研究[J]. 中华医院感染学杂志，2020, 30(7): 976-980.

平键，陈红云，周扬，等. 骨髓间充质干细胞移植对四氯化碳大鼠肝损伤的影响及一贯煎的干预作用[J]. 中国中药杂志，2018, 43(19): 3905-3912.

XU Y, FAN WW, XU W, et al. Yiguanjian decoction enhances fetal liver stem/progenitor cell-mediated repair of liver cirrhosis through regulation of macrophage activation state[J]. World J Gastroenterol, 2018, 24(42): 4759-4772.

谢斌，谢雄，饶斌，等. 一贯煎对肝癌JAK1/STAT1信号通路及其下游凋亡相关蛋白表达的影响[J]. 中国实验方剂学杂志，2017, 23(18): 100-104.

戚健君，李树德. 肝纤维化与NOX和ERK关系的研究进展[J]. 中国病原生物学杂志，2017, 12(12): 1225-1227.

谢斌，余功，饶斌，等. 一贯煎与环磷酰胺联用对肝癌VEGF及VEGFR2蛋白表达的影响[J]. 时珍国医国药，2015,26(9):2102-2104.

贾岚，王蕾蕾，孟靓，等. 白芍总苷对大鼠化学性肝损伤与肝阴虚证结合模型的影响和机制研究[J]. 中草药，2020, 51(7): 1885-1892.

CHEN Z, WANG X N, LI Y Y, et al. Comparative Network pharmacology analysis of classical TCM prescriptions for chronic liver disease[J/OL]. Front Pharmacol, 2019, 10: 1353[2020-02-25]. https: //pubmed. ncbi. nlm. nih. gov/31824313/https: //pubmed. ncbi. nlm. nih. gov/31824313/.

朱艳，夏芹芹，罗俊，等. 甲胎蛋白、甲胎蛋白异质体与TNF-α因子联合检测在原发性肝癌诊断中的应用价值[J]. 临床和实验医学杂志，2020, 19(4): 383-386.

VALENTI L, FRACANZANI A L, DONGIOVANNI P, et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease[J]. Gastroenterology, 2002, 122(2): 274-280.

TIAN M, LIU W, YOU H, et al. Protective effect of Yiguanjian decoction against DNA damage on concanavalin A-induced liver injury mice model[J]. J Tradit Chin Med, 2016, 36(4): 471-478.

刘文兰，油红捷，高连印，等. 一贯煎对肝炎小鼠模型TNF-α信号通路的影响[J]. 中华中医药杂志，2010, 25(4): 597-599

孟月，刘文兰，孙福慧. 一贯煎抑制肝星状细胞活化作用机制的研究[J]. 环球中医药，2018, 11(3): 326-330.

乔天阳，刘文兰，王文娟，等. 一贯煎及骨髓间充质干细胞对肝纤维化大鼠阴虚证表征影响的实验研究[J]. 环球中医药，2017, 10(4): 419-424.

ZHOU Y N, MU Y P, FU W W, et al. Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice[J]. BMC Complement Altern Med, 2015, 15(1): 342.

白辰，车念聪，刘文兰，等. 一贯煎对大鼠肝纤维化拮抗作用的影响[J]. 中华中医药杂志，2015, 30(3): 815-817.

郭敏，刘真，张丽慧，等. 一贯煎对大鼠肝星状细胞雌激素受体的影响[J]. 中医药信息，2020, 37(2): 20-24.

朱英，刘平. 一贯煎对DMN肝纤维化大鼠肝卵圆细胞增殖分化的影响[J]. 大连医科大学学报，2011, 33(1): 11-16

闫晓风，赵培，叶杰，等. 一贯煎通过上调自噬抑制H2O2诱导的肝细胞损伤[J]. 中华中医药杂志，2017, 32(2): 564-569.

FU L, PANG B, ZHU Y, et al. Ex vivo stromal cell-derived factor 1-mediated differentiation of mouse bone marrow mesenchymal stemcells into hepatocytes is enhanced by Chinese medicine Yiguanjian drug-containing serum[J/OL]. Evid Based Complement Alternat Med, 2016, 2016: 7380439[2020-02-25]. https: //pubmed. ncbi. nlm. nih. gov/27190538/https: //pubmed. ncbi. nlm. nih. gov/27190538/.

赵进喜，张保春，况时祥，等. 王孟英承先贤，集大成；《温热经纬》采各家，融寒温[J]. 环球中医药，2018, 11(5): 706-710.

Views

673

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on use of external therapy of traditional Chinese medicine in benign anorectal diseases

Chemical profiling of Huangqi Decoction granules and characterization of absorbed components and metabolites in mice plasma following oral administration based on UHPLC⁃Q⁃Exactive Orbitrap HRMS

Wang Lingtai’s experience in differentiating and treating chronic liver diseases based on the theory of “Danggui activating blood and Danshen harmonizing blood”

Wang Yiqin’s characteristics of clinical experience in syndrome differentiation and treatment of asthma by using classic prescriptions flexibly

Advances in chemical compositions， analytical methods and pharmacological effects of coumarins in Peucedani Radix

Related Author

No data

Related Institution

Guangming Traditional Chinese Medicine Hospital， Shanghai Pudong New Area

Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Institute of Liver Diseases， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine（TCM），MOE Key Laboratory of Liver and Kidney Diseases， Shanghai Key Laboratory of Traditional Chinese Clinical Medicine

SATCM Third Grade Laboratory of Traditional Chinese Medicine Preparations， Department of Pharmacy， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Pediatric， Baoshan Branch， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

⁰